102.095 articles found

Human iPSC-Derived Tissue-Engineered Nigrostriatal Pathway for Chronic Restoration of Dopaminergic Axon Tracts in a Rat Parkinson's Model.

Gordián-Vélez WJ, Chouhan D, Browne KD, Lim J, Karandikar SP, España RA, Duda JE, Chen HI, Cullen DK.

Adv Healthc Mater · 2026-10-03

DOI: 10.1002/adhm.71775PMID: 42829468

Targeting the temporal architecture of movement in Parkinson's disease.

Pauletti C, Suppa A.

Clin Neurophysiol · 2026-10-03

DOI: 10.1016/j.clinph.2026.2112422PMID: 42833893

Corrigendum to "Surface-enhanced Raman spectroscopy of serum exosomes coupled with support vector machine for diagnosis of Parkinson's disease" [Spectrochim. Acta Part A: Molecul. Biomolecul. Spectrosc. 353 (2026) 127573].

Liu X, Wei X, Zheng X, Xu L, Wu G, Feng K.

Spectrochim Acta A Mol Biomol Spectrosc · 2026-10-03

DOI: 10.1016/j.saa.2026.128860PMID: 42828938

A Two-Stage Questionnaire for Identifying Possible Parkinson’s Disease: Machine-Learning Feature Selection and Interim Prospective Validation in Almaty, Kazakhstan

Nagashybay A, Tokenov A, Mukushev M, Shider G, Sultamuratova F, Abdikenov B, Zhantleuova A, Lepesova M, Kustubayeva A, Karimova A.

· 2026-10-02

DOI: 10.20944/preprints202610.0123.v1

Shared and distinct effects of cognitive performance and mood on cognition-dependent instrumental activities of daily living in Parkinson’s disease

Hu JY, Sun S, Sharp M.

· 2026-10-02

DOI: 10.64898/2026.10.01.26364514

Interaction Between Exercise Intensity and Sedentary Behavior on VO ₂ max Change in Patients with De Novo Parkinson Disease: The Study in Parkinson Disease of Exercise (SPARX) Phase 2 Randomized Clinical Trial

Pae BJ, Novak TS, Griffith GJ, Patterson CG, Hackney ME, Christiansen CL, Corcos DM, Nocera JR.

· 2026-10-02

DOI: 10.64898/2026.09.30.26364437

<i>TMEM106B</i> analysis in diverse cohorts suggests no association with Parkinson’s disease risk

Chaparro-Solano HM, Kanagasingam S, Gan-Or Z, Senkevich K, the Global Parkinson’s Genetic Program (GP2).

· 2026-10-02

DOI: 10.64898/2026.09.28.26363833

Interaction Between Exercise Intensity and Sedentary Behavior on VO 2 max Change in Patients with De Novo Parkinson Disease: The Study in Parkinson Disease of Exercise (SPARX) Phase 2 Randomized Clinical Trial

Check source for author details

medRxiv · 2026-10-02

TMEM106B analysis in diverse cohorts suggests no association with Parkinson’s disease risk

Check source for author details

medRxiv · 2026-10-02

Automated eye-tracking for Parkinson's disease diagnosis: a proof-of-concept cascade classifier study.

Menke JM, Aslam S, Rieiro H, Waldorf R, Shill HA.

Clin Park Relat Disord · 2026-10-02

DOI: 10.1016/j.prdoa.2026.100509PMID: 42876454

Comprehensive genetic screening of the South African Parkinson's disease study collection using the NeuroBooster array.

Step K, Madula L, Kuznetsov N, Maasdorp E, Carr J, van Coller R, Möller M, Mata IF, Bardien S, Global Parkinson's Genetics Program (GP2).

Clin Park Relat Disord · 2026-10-02

DOI: 10.1016/j.prdoa.2026.100508PMID: 42890374

An &lt;i&gt;in silico&lt;/i&gt; cortico-basal ganglia-thalamic testbed for comparing visual and deep brain stimulation in Parkinson's disease.

Huang CH, Chen WS, Lai JR, Cho CH, Sung YT, Chang CT, Lin CW.

Front Comput Neurosci · 2026-10-02

DOI: 10.3389/fncom.2026.1950516PMID: 42890761